RegenLab USA, Inc. (RGNA)

RegenLab USA will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

RegenLab USA Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-1.14	-1.24	2.31
Depreciation & Amortization	1.09	0.88	2.98
Other Operating Activities	4.14	-0.19	-0.86
Operating Cash Flow	4.09	-0.54	4.43
Operating Cash Flow Growth	-	-	-

Investing Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Capital Expenditures	-1.29	-1.57	-3.16
Other Investing Activities	0.09	-	0.2
Investing Cash Flow	-1.2	-1.57	-2.96

Financing Activities

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt Issued / Paid	-	3.58	-3.03
Financing Cash Flow	-1.07	3.58	-3.03

Net Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash Flow	2.17	0.89	-1.06

Free Cash Flow

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	2.8	-2.11	1.28
Free Cash Flow Growth	-	-	-
Free Cash Flow Margin	5.16%	-4.30%	2.64%